FI47488C - Menetelmä 1-alkyyli-2,3-dihydro-5-fenyyli-1H-1,4-bentsodiatsepiinien v almistamiseksi. - Google Patents

Menetelmä 1-alkyyli-2,3-dihydro-5-fenyyli-1H-1,4-bentsodiatsepiinien v almistamiseksi.

Info

Publication number
FI47488C
FI47488C FI671542A FI154267A FI47488C FI 47488 C FI47488 C FI 47488C FI 671542 A FI671542 A FI 671542A FI 154267 A FI154267 A FI 154267A FI 47488 C FI47488 C FI 47488C
Authority
FI
Finland
Prior art keywords
benzodiazepines
dihydro
phenyl
alkyl
preparation
Prior art date
Application number
FI671542A
Other languages
English (en)
Swedish (sv)
Other versions
FI47488B (fi
Inventor
Kaegi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to FI47173A priority Critical patent/FI55178C/fi
Application granted granted Critical
Publication of FI47488B publication Critical patent/FI47488B/fi
Publication of FI47488C publication Critical patent/FI47488C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI671542A 1966-06-03 1967-05-31 Menetelmä 1-alkyyli-2,3-dihydro-5-fenyyli-1H-1,4-bentsodiatsepiinien v almistamiseksi. FI47488C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI47173A FI55178C (fi) 1966-06-03 1973-02-16 Vid framstaellning av 2 3-dihydro-1 4-bensodiazepiner saosom mellanprodukter anvaendbara n-(p-klorfenyl)-n-alkyl-n'-bensoyletylendiaminer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55496466A 1966-06-03 1966-06-03

Publications (2)

Publication Number Publication Date
FI47488B FI47488B (fi) 1973-08-31
FI47488C true FI47488C (fi) 1973-12-10

Family

ID=24215433

Family Applications (1)

Application Number Title Priority Date Filing Date
FI671542A FI47488C (fi) 1966-06-03 1967-05-31 Menetelmä 1-alkyyli-2,3-dihydro-5-fenyyli-1H-1,4-bentsodiatsepiinien v almistamiseksi.

Country Status (17)

Country Link
US (1) US3501460A (fi)
BE (1) BE699047A (fi)
CH (1) CH483434A (fi)
CY (1) CY507A (fi)
DE (1) DE1695188C3 (fi)
DK (1) DK116288B (fi)
ES (1) ES341311A1 (fi)
FI (1) FI47488C (fi)
GB (1) GB1153101A (fi)
GR (1) GR36820B (fi)
IL (1) IL27980A (fi)
MY (2) MY6900417A (fi)
NL (1) NL6707722A (fi)
NO (2) NO136976C (fi)
OA (1) OA02443A (fi)
SE (2) SE321683B (fi)
YU (1) YU32366B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723414A (en) * 1970-02-13 1973-03-27 Schering Corp 1-polyfluoroalkyl benzodiazepines
DE2221558C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
CY507A (en) 1969-11-19
DK116288B (da) 1969-12-29
SE357963B (fi) 1973-07-16
SE321683B (fi) 1970-03-16
GB1153101A (en) 1969-05-21
YU32366B (en) 1974-10-31
NO136976C (no) 1977-12-07
BE699047A (fi) 1967-11-27
DE1695188A1 (de) 1971-04-08
NL6707722A (fi) 1967-12-04
NO137937B (no) 1978-02-13
GR36820B (el) 1969-03-12
MY7000025A (en) 1970-12-31
FI47488B (fi) 1973-08-31
IL27980A (en) 1971-10-20
NO137937C (no) 1978-05-24
NO136976B (no) 1977-08-29
CH483434A (de) 1969-12-31
DE1695188B2 (de) 1980-04-17
MY6900417A (en) 1969-12-31
YU109867A (en) 1974-04-30
OA02443A (fr) 1970-05-05
ES341311A1 (es) 1968-10-16
US3501460A (en) 1970-03-17
DE1695188C3 (de) 1980-12-11

Similar Documents

Publication Publication Date Title
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
FI48722C (fi) Menetelmä 3-metyylipenteenien valmistamiseksi.
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK112441B (da) Fremgangsmåde til fremstilling af L-lysin.
DK137493B (da) Fremgangsmåde til fremstilling af quinoxalin-di-N-oxyder.
FI50977C (fi) Menetelmä 7-kloori-5-fenyyli-1,4-bentsodiatsepiinien valmistamiseksi.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI47488C (fi) Menetelmä 1-alkyyli-2,3-dihydro-5-fenyyli-1H-1,4-bentsodiatsepiinien v almistamiseksi.
FI47576C (fi) Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
FI48090C (fi) Menetelmä 1-syaaniaminoalkyyli-2H-1,4-bentsodiatsepiini-2-oni-johdanna isten valmistamiseksi
DK123649B (da) Fremgangsmåde til fremstilling af L-lysin.
DK115551B (da) Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider.
FI50710C (fi) Menetelmä 1,4-bentsodiatsepiinien valmistamiseksi.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK114063B (da) Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol.
FI47370C (fi) Menetelmä valmistaa 1-metyyli-7-halogeeni-2,3-dihydro-5-fenyyli-1,4-be ntsodiatsepiinejä.
DK122080B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
FI48352C (fi) Menetelmä 1-alkyyli-2,3-dihydro-1H-1,4-bentsodiatsepiinien valmistamis eksi.
FI45172C (fi) Menetelmä 17alfa-asyylioksi-6-kloori-1,2alfa-metyleeni-21-fluori- 4,6- pregnadieenien valmistamiseksi.
FI49168C (fi) Menetelmä 7-halogeeni-1-alkyyli-5-fenyyli-2,3-dihydro-1H-1,4-bentso-di atsepiinien valmistamiseksi.
FI45952C (fi) Menetelmä formaldehydin valmistamiseksi.
FI45324C (fi) Menetelmä 17beta-(1-alkoksi-sykloalkyyli)oksi-2alfa,3alfa-epitio-5alfa -androstaanien valmistamiseksi.
DK114626B (da) Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin.